The Cystic Fibrosis Foundation Patient Registry. Design and Methods of a National Observational Disease Registry.
暂无分享,去创建一个
Aliza K Fink | Alexander Elbert | Emily A. Knapp | Emily A Knapp | C. Goss | B. Marshall | Christopher H Goss | A. Sewall | Bruce C Marshall | Ase Sewall | Josh Ostrenga | Christopher Dowd | Kristofer M Petren | A. Fink | A. Elbert | J. Ostrenga | K. Petren | C. Dowd | Josh Ostrenga
[1] T. Liou,et al. Lung transplantation and survival in children with cystic fibrosis. , 2007, The New England journal of medicine.
[2] C. Penland,et al. Cystic fibrosis foundation: achieving the mission. , 2009, Respiratory care.
[3] S. Somers. Improving chronic care. , 2002, Health affairs.
[4] D. Sanders,et al. Outcomes of Infants With Indeterminate Diagnosis Detected by Cystic Fibrosis Newborn Screening , 2015, Pediatrics.
[5] C. Kaye. Newborn Screening Fact Sheets , 2006, Pediatrics.
[6] D. Sanders,et al. Short-term and long-term response to pulmonary exacerbation treatment in cystic fibrosis , 2015, Thorax.
[7] S. Grosse,et al. Variation in immunoreactive trypsinogen concentrations among michigan newborns and implications for cystic fibrosis newborn screening , 2011, Pediatric pulmonology.
[8] R. Parad,et al. Newborn screening showing decreasing incidence of cystic fibrosis. , 2008, The New England journal of medicine.
[9] A. Thompson,et al. Novel CFTR variants identified during the first 3 years of cystic fibrosis newborn screening in California. , 2013, The Journal of molecular diagnostics : JMD.
[10] J. Zieleński,et al. Two-tiered immunoreactive trypsinogen-based newborn screening for cystic fibrosis in Colorado: screening efficacy and diagnostic outcomes. , 2005, The Journal of pediatrics.
[11] Vicky A Legrys,et al. Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report. , 2008, The Journal of pediatrics.
[12] R. Parad,et al. Population-based newborn screening for genetic disorders when multiple mutation DNA testing is incorporated: a cystic fibrosis newborn screening model demonstrating increased sensitivity but more carrier detections. , 2004, Pediatrics.
[13] S. Stanojevic,et al. A standardized approach to estimating survival statistics for population-based cystic fibrosis registry cohorts. , 2016, Journal of clinical epidemiology.
[14] M. Rosenfeld,et al. Opportunities and pitfalls of registry data for clinical research. , 2013, Paediatric respiratory reviews.
[15] Mats Lundström,et al. Use of 13 disease registries in 5 countries demonstrates the potential to use outcome data to improve health care's value. , 2012, Health affairs.
[16] Emily A. Knapp,et al. Children and young adults with CF in the USA have better lung function compared with the UK , 2014, Thorax.
[17] C. Goss,et al. Effect of ambient air pollution on pulmonary exacerbations and lung function in cystic fibrosis. , 2004, American journal of respiratory and critical care medicine.
[18] F. Lorey,et al. Birth prevalence of disorders detectable through newborn screening by race/ethnicity , 2012, Genetics in Medicine.
[19] J. Nick,et al. Effects of gender and age at diagnosis on disease progression in long-term survivors of cystic fibrosis. , 2010, American journal of respiratory and critical care medicine.
[20] S. Fitzsimmons. The changing epidemiology of cystic fibrosis. , 1994, Current problems in pediatrics.
[21] A. Dias,et al. Sleep pathology characterization in sickle cell disease: Case–control study , 2015, Pediatric pulmonology.
[22] Peter Davey,et al. A checklist for retrospective database studies--report of the ISPOR Task Force on Retrospective Databases. , 2003, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[23] R. Laessig,et al. Newborn screening for cystic fibrosis in Wisconsin: nine-year experience with routine trypsinogen/DNA testing. , 2005, The Journal of pediatrics.
[24] Laura Marrow,et al. Improving chronic care delivery and outcomes: the impact of the cystic fibrosis Care Center Network , 2014, BMJ quality & safety.
[25] Douglas G Altman,et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies. , 2014, International journal of surgery.
[26] Douglas G Altman,et al. [The Strengthening the Reporting of Observational Studies in Epidemiology [STROBE] statement: guidelines for reporting observational studies]. , 2007, Gaceta sanitaria.
[27] J. Wakefield,et al. Fine particulate matter exposure and initial Pseudomonas aeruginosa acquisition in cystic fibrosis. , 2015, Annals of the American Thoracic Society.
[28] C. Goss,et al. The Cystic Fibrosis Foundation Patient Registry as a tool for use in quality improvement , 2014, BMJ quality & safety.
[29] J Rick Turner,et al. Characterization of Missing Data in Clinical Registry Studies , 2015, Therapeutic innovation & regulatory science.